Alnylam Pharmaceuticals, Inc.
2018 Q3 - 2025 Q4 (19 filings)
Shares History
History scope: non-option holdings only (PUT/CALL rows excluded).
| All 13F Holders | Filing date | Value ($000s) | % of Holdings | Shares | Reporting period |
|---|---|---|---|---|---|
| 2025 Q4 | 2/12/2026 | 3,256 | 0.0% | 8,187 | 12/31/2025 |
| 2025 Q3 | 11/13/2025 | 3,644 | 0.0% | 7,992 | 9/30/2025 |
| 2025 Q2 | 8/13/2025 | 2,531 | 0.0% | 7,761 | 6/30/2025 |
| 2025 Q1 | 5/14/2025 | 1,970 | 0.0% | 7,295 | 3/31/2025 |
| 2024 Q4 | 2/13/2025 | 1,719 | 0.0% | 7,304 | 12/31/2024 |
| 2024 Q3 | 11/13/2024 | 2,013 | 0.0% | 7,318 | 9/30/2024 |
| 2024 Q2 | 8/13/2024 | 1,813 | 0.0% | 7,462 | 6/30/2024 |
| 2024 Q1 | 5/14/2024 | 987 | 0.0% | 6,606 | 3/31/2024 |
| 2023 Q4 | 4/22/2024 | 1,245 | 0.0% | 6,504 | 12/31/2023 |
| 2023 Q3 | 5/9/2024 | 1,168 | 0.0% | 6,596 | 9/30/2023 |
| 2023 Q2 | 4/29/2024 | 1,252 | 0.0% | 6,592 | 6/30/2023 |
| 2023 Q1 | 5/9/2024 | 1,492 | 0.0% | 7,450 | 3/31/2023 |
| 2022 Q4 | 5/10/2024 | 1,766 | 0.0% | 7,432 | 12/31/2022 |
| 2022 Q3 | 5/10/2024 | 1,499 | 0.0% | 7,490 | 9/30/2022 |
| 2022 Q2 | 5/10/2024 | 1,092 | 0.0% | 7,485 | 6/30/2022 |
| 2022 Q1 | 5/10/2024 | 1,268 | 0.0% | 7,763 | 3/31/2022 |
| 2019 Q1 | 7/13/2023 | 12 | 0.0% | 129 | 3/31/2019 |
| 2018 Q4 | 7/13/2023 | 9 | 0.0% | 122 | 12/31/2018 |
| 2018 Q3 | 7/13/2023 | 11 | 0.0% | 123 | 9/30/2018 |